title: A new versatile and compact lentiviral vector.
abstract: During the past decade, lentiviral vectors based on the HIV-1 genome have been developed to become highly useful tools for efficient and stable delivery of transgenes to dividing and nondividing cells in a variety of experimental protocols. The vector system has been progressively and substantially improved,mainly to meet growing concerns over safety issues. However, the actual design and size of the lentiviral transfer vector often makes transgene cloning and DNA preparation a troublesome task. In this study, the pHR transfer vector used for lentivirus production in many laboratories was modified to contain a more versatile polylinker than the one present in the original pHR vector. In addition, the vector was significantly reduced in size from 12 to 7 kb, by replacing the original vector backbone with sequence from the multipurpose pUC18 vector. These modifications allowed for easier cloning and higher DNA yields without compromising the fundamental ability of this vector system to transduce cells in vitro and in vivo. Finally, the trimmed vector sequence was fully characterized by sequencing the vector in its entirety. In both cultured cells and directly into the rat striatum, transduction with this lentivirus, based on the modified pHsCXW vector, was as efficient and durable as with the pHR vector-based virus. In conclusion, the modified lentiviral transfer vector pHsCXW holds promise as a new valuable tool for the research community in the field of gene transfer.
authors.affiliation: NsGene A/S, Baltorpvej 154, DK-2750 Ballerup, Denmark. jjha@lundbeck.com
authors.forename: Jens
authors.initials: J
authors.lastname: Leander Johansen
authors.forename: Lone
authors.initials: L
authors.lastname: Dagø
authors.forename: Jens
authors.initials: J
authors.lastname: Tornøe
authors.forename: Carl
authors.initials: C
authors.lastname: Rosenblad
authors.forename: Philip
authors.initials: P
authors.lastname: Kusk
mesh_terms: D000818:Animals; D002460:Cell Line; D005260:Female; D015316:Genetic Therapy / Q000379:methods; D005822:Genetic Vectors / Q000235:genetics* / Q000627:therapeutic use; D016679:Genome, Viral / Q000235:genetics*; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D051381:Rats; D017207:Rats, Sprague-Dawley; D017422:Sequence Analysis, DNA; D014161:Transduction, Genetic / Q000379:methods; D019076:Transgenes / Q000235:genetics